Novocure Ltd (NVCR) CEO Asaf Danziger Sold $9 million of Shares

CEO of Novocure Ltd (NVCR, Financial) Asaf Danziger sold 200,000 shares of NVCR on 01/17/2019 at an average price of $45.16 a share. The total sale was $9 million.

NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors. NovoCure Ltd has a market cap of $4.32 billion; its shares were traded at around $46.45 with and P/S ratio of 17.49.

CEO Recent Trades:

  • CEO Asaf Danziger sold 200,000 shares of NVCR stock on 01/17/2019 at the average price of $45.16. The price of the stock has increased by 2.86% since.
  • CEO Asaf Danziger sold 200,000 shares of NVCR stock on 01/15/2019 at the average price of $43.51. The price of the stock has increased by 6.76% since.

CFO Recent Trades:

  • CFO Wilhelmus Cm Groenhuysen sold 30,000 shares of NVCR stock on 01/15/2019 at the average price of $44.2. The price of the stock has increased by 5.09% since.
  • CFO Wilhelmus Cm Groenhuysen sold 30,000 shares of NVCR stock on 01/11/2019 at the average price of $42.35. The price of the stock has increased by 9.68% since.

Directors and Officers Recent Trades:

  • Chief Science Officer Eilon D. Kirson sold 168,813 shares of NVCR stock on 01/17/2019 at the average price of $45.17. The price of the stock has increased by 2.83% since.
  • Director Gabriel Leung sold 20,000 shares of NVCR stock on 01/16/2019 at the average price of $45. The price of the stock has increased by 3.22% since.
  • Chief Commercial Officer Pritesh Shah sold 25,000 shares of NVCR stock on 01/16/2019 at the average price of $45. The price of the stock has increased by 3.22% since.
  • General Counsel Todd Christopher Longsworth sold 15,000 shares of NVCR stock on 01/16/2019 at the average price of $45.15. The price of the stock has increased by 2.88% since.
  • Chief Commercial Officer Pritesh Shah sold 26,251 shares of NVCR stock on 01/11/2019 at the average price of $42. The price of the stock has increased by 10.6% since.

For the complete insider trading history of NVCR, click here

.